Efficacy and Safety Study of MYOBLOC® in the Treatment of Adult Lower Limb Spasticity
Clinical trial NCT04099667 · TERMINATED
Trial details
- NCT number
- NCT04099667
- Sponsor
- Solstice Neurosciences, LLC, a subsidiary of MDD US Operations, LLC
- Status
- TERMINATED
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2019-12-17
- Primary completion
- 2023-03-24
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.